NCT05224310

Brief Summary

The use of pectoral nerve block (PECSB) is a new technique during modified radical mastectomy MRM. The Serratus anterior Plane (SAP) Block has been proven to be an effective component of multimodal analgesia regimens for a variety of thoracic procedures including MRM. In this study, the investigators will assess and compare the quality of analgesia with ultrasound-guided Serratus plane block and pectoral nerve block in patients undergoing modified radical mastectomy MRM.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 24, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 4, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2022

Completed
Last Updated

August 5, 2022

Status Verified

August 1, 2022

Enrollment Period

3 months

First QC Date

January 24, 2022

Last Update Submit

August 4, 2022

Conditions

Keywords

analgesiapostoperative painPECS blockSAP block

Outcome Measures

Primary Outcomes (1)

  • The first request for analgesia

    the time from the completion of the block to the time of the first request for analgesia.

    immediately at the end of 24 hours post operatively

Secondary Outcomes (1)

  • Post-operative pain

    immediately postoperatively 0,2,4,6,8,12,14,16,18,20,22,and 24 h after surgery at rest

Study Arms (2)

Pectoral nerve block

ACTIVE COMPARATOR

Starting from the lateral third of the clavicle and moving distally and laterally to the midaxillary line. The pectoral major and minor muscles will be identified and 10 mL of bupivacaine 0.25% will be injected between the 2 muscles, and then move the ultrasound probe towards the axilla until the serratus anterior is identified above the second, third, and fourth ribs then injection of 20 mL of bupivacaine 0.25% after negative aspiration into the fascial plane between pectoralis minor and serratus anterior muscles.

Procedure: PECS block, SAP block

Serratus anterior plane block

ACTIVE COMPARATOR

Aiming to find the serratus anterior muscle the investigator will identify the fifth rib in the midaxillary line by the linear probe in the sagittal plane. The latissimus dorsi muscle (superficial and posterior), teres major muscle (superior) and serratus muscles (deep and inferior) will be detected using ultrasound. The investigator will penetrate the serratus anterior muscle by a 23 GA, 35 mm needle in-plane to ultrasound probe from supero-anterior to postero-inferior to inject deep to it.

Procedure: PECS block, SAP block

Interventions

performing either PECS block or SAP block

Pectoral nerve blockSerratus anterior plane block

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsfemale patients with breast cancer undergoing modified radical mastectomy surgery under general anaesthesia
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult, female patients,
  • ASA physical status I, II, and III
  • Aged older than 18 years
  • Scheduled for modified radical mastectomy surgery under general anaesthesia.

You may not qualify if:

  • Any known allergies to the study drugs.
  • Apparent anatomical abnormalities or infections in the serratus region.
  • Bleeding disorders e.g. thrombocytopenia, high INR, high PT in the chronic liver or impaired kidney).
  • Patients on chronic pain medications or regularly receiving analgesics.
  • Pregnant or breastfeeding patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Suez Canal University

Ismailia, 2685, Egypt

Location

MeSH Terms

Conditions

Breast NeoplasmsAgnosiaPain, Postoperative

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesPain

Study Officials

  • Abdelrhman Alshawadfy, MD

    Suez Canal University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of anesthesia and intensive care

Study Record Dates

First Submitted

January 24, 2022

First Posted

February 4, 2022

Study Start

April 1, 2022

Primary Completion

June 30, 2022

Study Completion

July 30, 2022

Last Updated

August 5, 2022

Record last verified: 2022-08

Locations